Quarterly Result14 Feb 2026, 05:32 pm
Omkar Pharmachem Ltd. Approves Unaudited Financial Results for Quarter & Nine Months Ended on 31st December, 2025
AI Summary
Omkar Pharmachem Ltd. has approved the unaudited financial results for the quarter and nine months ended on 31st December, 2025. The company's total income stands at Rs. 4,072 lakhs and Rs. 5,422 lakhs respectively. The profit before tax for the quarter and nine months is Rs. 1,372 lakhs and Rs. 1,030 lakhs respectively. The company's total expenses for the quarter and nine months are Rs. 3,094 lakhs and Rs. 4,382 lakhs respectively. The company's earnings per share before and after extraordinary items for the quarter is Rs. 0.22 and Rs. 0.1059 respectively. The company's earnings per share before and after extraordinary items for the nine months is Rs. 0.2205 and Rs. 0.0293 respectively.
Key Highlights
- Omkar Pharmachem Ltd. approves unaudited financial results for the quarter and nine months ended on 31st December, 2025.
- The company's total income for the quarter and nine months ended on 31st December, 2025 stands at Rs. 4,072 lakhs and Rs. 5,422 lakhs respectively.
- The profit before tax for the quarter and nine months ended on 31st December, 2025 is Rs. 1,372 lakhs and Rs. 1,030 lakhs respectively.
- The company's total expenses for the quarter and nine months ended on 31st December, 2025 are Rs. 3,094 lakhs and Rs. 4,382 lakhs respectively.
- The company's earnings per share before and after extraordinary items for the quarter is Rs. 0.22 and Rs. 0.1059 respectively. The company's earnings per share before and after extraordinary items for the nine months is Rs. 0.2205 and Rs. 0.0293 respectively.
Price Impact
More from OMKARPH